Skip to main navigation Skip to search Skip to main content

TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A

  • NYGC ALS Consortium
  • University College London
  • The Francis Crick Institute
  • National Institutes of Health
  • New York Genome Cente
  • Temple University
  • University of California at Los Angeles
  • Pennsylvania State University
  • Henry Ford Health System
  • University of Pennsylvania
  • Columbia University
  • Massachusetts Institute of Technology
  • Johns Hopkins University
  • Academic Medical Center
  • Leiden University
  • University of California at San Francisco
  • Harvard University
  • Massachusetts General Hospital
  • Queen Mary University of London
  • Mid and South Essex NHS Foundation Trust
  • Jackson Laboratory
  • University of California at Irvine
  • Gladstone Institutes
  • University of Thessaly
  • Washington University St. Louis
  • University of Edinburgh
  • Weizmann Institute of Science
  • Icahn School of Medicine at Mount Sinai
  • Cold Spring Harbor Laboratory
  • St. Joseph's Hospital and Medical Center, Phoenix
  • University of Amsterdam

Research output: Contribution to journalArticlepeer-review

335 Scopus citations

Abstract

Variants of UNC13A, a critical gene for synapse function, increase the risk of amyotrophic lateral sclerosis and frontotemporal dementia1–3, two related neurodegenerative diseases defined by mislocalization of the RNA-binding protein TDP-434,5. Here we show that TDP-43 depletion induces robust inclusion of a cryptic exon in UNC13A, resulting in nonsense-mediated decay and loss of UNC13A protein. Two common intronic UNC13A polymorphisms strongly associated with amyotrophic lateral sclerosis and frontotemporal dementia risk overlap with TDP-43 binding sites. These polymorphisms potentiate cryptic exon inclusion, both in cultured cells and in brains and spinal cords from patients with these conditions. Our findings, which demonstrate a genetic link between loss of nuclear TDP-43 function and disease, reveal the mechanism by which UNC13A variants exacerbate the effects of decreased TDP-43 function. They further provide a promising therapeutic target for TDP-43 proteinopathies.

Original languageEnglish
Pages (from-to)131-137
Number of pages7
JournalNature
Volume603
Issue number7899
DOIs
StatePublished - Mar 3 2022

Fingerprint

Dive into the research topics of 'TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A'. Together they form a unique fingerprint.

Cite this